Hudock Inc’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-242
| Closed | – | – | 786 |
|
|
2022
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 839 |
|
|
2022
Q2 | $0 | Hold |
242
| – | – | ﹤0.01% | 823 |
|
|
2022
Q1 | $0 | Hold |
242
| – | – | ﹤0.01% | 822 |
|
|
2021
Q4 | $0 | Hold |
242
| – | – | ﹤0.01% | 896 |
|
|
2021
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 901 |
|
|
2021
Q2 | $0 | Hold |
242
| – | – | ﹤0.01% | 878 |
|
|
2021
Q1 | $0 | Hold |
242
| – | – | ﹤0.01% | 854 |
|
|
2020
Q4 | $0 | Hold |
242
| – | – | ﹤0.01% | 812 |
|
|
2020
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 804 |
|
|
2020
Q2 | $0 | Hold |
242
| – | – | ﹤0.01% | 795 |
|
|
2020
Q1 | $0 | Hold |
242
| – | – | ﹤0.01% | 768 |
|
|
2019
Q4 | $0 | Hold |
242
| – | – | ﹤0.01% | 737 |
|
|
2019
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 755 |
|
|
2019
Q2 | $0 | Hold |
242
| – | – | ﹤0.01% | 730 |
|
|
2019
Q1 | $0 | Hold |
242
| – | – | ﹤0.01% | 724 |
|
|
2018
Q4 | $0 | Hold |
242
| – | – | ﹤0.01% | 717 |
|
|
2018
Q3 | $0 | Hold |
242
| – | – | ﹤0.01% | 715 |
|
|
2018
Q2 | $1K | Hold |
242
| – | – | ﹤0.01% | 642 |
|
|
2018
Q1 | $1K | Hold |
242
| – | – | ﹤0.01% | 642 |
|
|
2017
Q4 | $1K | Hold |
242
| – | – | ﹤0.01% | 621 |
|
|
2017
Q3 | $2K | Hold |
242
| – | – | ﹤0.01% | 589 |
|
|
2017
Q2 | $2K | Hold |
242
| – | – | ﹤0.01% | 545 |
|
|
2017
Q1 | $2K | Hold |
242
| – | – | ﹤0.01% | 519 |
|
|
2016
Q4 | $1K | Hold |
242
| – | – | ﹤0.01% | 541 |
|
|
2016
Q3 | $1K | Sell |
242
-138
| -36% | -$824 | ﹤0.01% | 551 |
|
|
2016
Q2 | $2K | Hold |
380
| – | – | ﹤0.01% | 538 |
|
|
2016
Q1 | $1K | Hold |
380
| – | – | ﹤0.01% | 565 |
|
|
2015
Q4 | $1K | Hold |
380
| – | – | ﹤0.01% | 531 |
|
|
2015
Q3 | $1K | Hold |
380
| – | – | ﹤0.01% | 558 |
|
|
2015
Q2 | $1K | Hold |
380
| – | – | ﹤0.01% | 560 |
|
|
2015
Q1 | $1K | Hold |
380
| – | – | ﹤0.01% | 580 |
|
|
2014
Q4 | $2K | Hold |
380
| – | – | ﹤0.01% | 513 |
|
|
2014
Q3 | $2K | Hold |
380
| – | – | ﹤0.01% | 537 |
|
|
2014
Q2 | $2K | Hold |
380
| – | – | ﹤0.01% | 548 |
|
|
2014
Q1 | $2K | Hold |
380
| – | – | ﹤0.01% | 521 |
|
|
2013
Q4 | $1K | Hold |
380
| – | – | ﹤0.01% | 559 |
|
|
2013
Q3 | $1K | Hold |
380
| – | – | ﹤0.01% | 510 |
|
|
2013
Q2 | $1K | Buy |
+380
| New | +$839 | ﹤0.01% | 506 |
|
Other funds holding ENZ
HFA
RAM
PCM
BCM
Hudock Inc's ENZ Position: Q4 2022 in Review
Hudock Inc sold out of Enzo Biochem, Inc. (ENZ) in Q4 2022, closing a stake of 242 shares.
Hudock Inc first reported a position in ENZ in Q2 2013 and held it in 38 quarters. The position peaked at $2K in Q3 2017. 52 funds tracked by Wall St. Rank hold ENZ as of Q4 2022.
- Hudock Inc reported no remaining Enzo Biochem, Inc. position as of Q4 2022 after selling out during the quarter.
- Hudock Inc sold 242 Enzo Biochem, Inc. shares in Q4 2022.
- Hudock Inc first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 38 quarters.
- Hudock Inc's Enzo Biochem, Inc. position peaked at $2K in Q3 2017.
- 52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2022.
Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.